Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Morgan

Showing results (61-70 of 247) with videos related to

Pageof 25
Sort By:
Biochemical and Biophysical Research Communications|January 31, 1985
2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocytes attacked by complementP A Roberts, B P Morgan, A K Campbell
Biochemistry|July 12, 1988
Comparison between complement and melittin hemolysis: anti-melittin antibodies inhibit complement lysisR O Laine, B P Morgan, A F Esser
Biochemical Society Transactions|November 21, 2002
Tailoring anti-complement therapeuticsC L Harris, D A Fraser, B P Morgan
Clinical and Experimental Immunology|September 1, 1988
Measurement of terminal complement complexes in rheumatoid arthritisB P Morgan, R H Daniels, B D Williams
Immunology|August 14, 1999
Tissue distribution of the rat analogue of decay-accelerating factorO B Spiller, S M Hanna, B P Morgan
The Biochemical Journal|July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)C L Harris, N K Rushmere, B P Morgan
Immunology|August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesC L Harris, O B Spiller, B P Morgan
Journal of Neuroimmunology|May 26, 1998
The expression of complement regulatory proteins by adult human oligodendrocytesN J Scolding, B P Morgan, D A Compston
British Journal of Rheumatology|August 1, 1986
The ninth complement component in rheumatoid arthritis, Behçet's disease and other rheumatic diseasesW R Rumfeld, B P Morgan, A K Campbell
Biochemical and Biophysical Research Communications|January 30, 1984
Inhibition of complement-induced [14C]sucrose release by intracellular and extracellular monoclonal antibodies to C9: evidence that C9 is a transmembrane proteinB P Morgan, J P Luzio, A K Campbell
Pageof 25

Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Biochemical and Biophysical Research Communications|January 31, 1985
2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocytes attacked by complementP A Roberts, B P Morgan, A K Campbell
Biochemistry|July 12, 1988
Comparison between complement and melittin hemolysis: anti-melittin antibodies inhibit complement lysisR O Laine, B P Morgan, A F Esser
Biochemical Society Transactions|November 21, 2002
Tailoring anti-complement therapeuticsC L Harris, D A Fraser, B P Morgan
Clinical and Experimental Immunology|September 1, 1988
Measurement of terminal complement complexes in rheumatoid arthritisB P Morgan, R H Daniels, B D Williams
Immunology|August 14, 1999
Tissue distribution of the rat analogue of decay-accelerating factorO B Spiller, S M Hanna, B P Morgan
The Biochemical Journal|July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)C L Harris, N K Rushmere, B P Morgan
Immunology|August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesC L Harris, O B Spiller, B P Morgan
Journal of Neuroimmunology|May 26, 1998
The expression of complement regulatory proteins by adult human oligodendrocytesN J Scolding, B P Morgan, D A Compston
British Journal of Rheumatology|August 1, 1986
The ninth complement component in rheumatoid arthritis, Behçet's disease and other rheumatic diseasesW R Rumfeld, B P Morgan, A K Campbell
Biochemical and Biophysical Research Communications|January 30, 1984
Inhibition of complement-induced [14C]sucrose release by intracellular and extracellular monoclonal antibodies to C9: evidence that C9 is a transmembrane proteinB P Morgan, J P Luzio, A K Campbell
Pageof 25